0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Research Letter |  ONLINE FIRST
William Toppen, BA; Sohail Sareh, MS; Daniel Johansen, BA; et al.
JAMA Surg. Published online November 18, 2015. doi:10.1001/jamasurg.2015.4212

Invited Commentary |  ONLINE FIRST
Claudio Baracchini, MD; Enzo Ballotta, MD
JAMA Surg. Published online October 21, 2015. doi:10.1001/jamasurg.2015.3615

Original Investigation | 
Mark L. Friedell, MD; Charles W. Van Way III, MD; Ron W. Freyberg, MS; et al.
JAMA Surg. 2015;150(7):658-663. doi:10.1001/jamasurg.2015.86.
Includes: CME

Original Investigation |  FREE
Eileen M. Bulger, MD; Ronald V. Maier, MD; Jason Sperry, MD; et al.
JAMA Surg. 2014;149(6):528-536. doi:10.1001/jamasurg.2013.4841.
Includes: CME, Supplemental Content

Invited Critique | 
Martin A. Makary, MD, MPH
Arch Surg. 2007;142(3):284. doi:10.1001/archsurg.142.3.284.

Original Article |  FREE
Amy L. Friedman, MD; Sarah R. Geoghegan, BSN; Noelle M. Sowers, RN; et al.
Arch Surg. 2007;142(3):278-283. doi:10.1001/archsurg.142.3.278.
Includes: CME

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Original Investigation  | 
Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival A Systematic Review and Meta-analysis
Jonathan Douxfils, PharmD, PhD; Hélène Haguet, MBS; François Mullier, PharmD, PhD; et al.
JAMA Oncology
Review  | 
Toxic Effects of Sorafenib in Patients With Differentiated Thyroid Carcinoma Compared With Other Cancers
Gary W. Jean, PharmD; Rene M. Mani, PharmD; Aliza Jaffry, PharmD; et al.
JAMA
From The Medical Letter on Drugs and Therapeutics  | 
Drugs Past Their Expiration Date

JAMA Internal Medicine
Editorial  | 
Vitamin D Supplementation and Increased Risk of Falling A Cautionary Tale of Vitamin Supplements Retold
Steven R. Cummings, MD; Douglas P. Kiel, MD, MPH; Dennis M. Black, PhD